stockportfolio.pro
IDXX vs WAT: Which Stock Is the Better Buy?
IDEXX Laboratories, Inc. and Waters Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — IDXX vs WAT, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| IDEXX Laboratories, Inc. (IDXX) | Waters Corporation (WAT) | |
|---|---|---|
| Market cap | $44.0B | $37.2B |
| Revenue (latest FY) | $4.30B | $3.17B |
| Net income (latest FY) | $1.06B | $642.63M |
| Revenue growth (5y CAGR) | 9.7% | 6.0% |
| Net margin | 24.6% | 20.3% |
| Return on equity | 66.0% | 25.1% |
| P/E ratio | 41.0 | 48.3 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full IDXX vs WAT breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open IDXX's full financials → Open WAT's full financials →More comparisons
Frequently asked questions
Which is bigger, IDXX or WAT?
IDEXX Laboratories, Inc. is larger by market capitalization — $44.0B versus $37.2B.
Which grows faster, IDXX or WAT?
Over the last five fiscal years, IDEXX Laboratories, Inc. grew revenue faster — 9.7%/yr versus 6.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.